DAVID SABLE: Open Payments
NPI 1245216092 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,478 in 27 payments from 10 companies in 2025. Trend: 2023 $596 · 2024 $630 · 2025 $2,478
Consulting: $2,000Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $2,000 |
| ABBVIE INC. | 14 | $231 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Organogenesis Inc. | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| PFIZER INC. | 1 | $27 |
| GENZYME CORPORATION | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Odomzo, RINVOQ, SKYRIZI, COSENTYX, OTEZLA, CIBINQO, NOVACHOR, AYVAKIT.
Industry payments across FL — which companies pay providers there.
